article thumbnail

Icosavax co-founder and UW researcher Neil King talks vaccine development in the ‘digital era’

GeekWire

University of Washington vaccine researcher and Icosavax co-founder Neil King at the GeekWire Summit in Seattle on Tuesday. We are now in the “digital era” of vaccine development, University of Washington researcher Neil King said at the GeekWire Summit in Seattle on Tuesday. GeekWire Photo / Dan DeLong). Icosavax Photo).

Research 127
article thumbnail

Seattle biotech startup Deverra Therapeutics raising cash to develop cellular immunotherapies

GeekWire

Colleen Delaney, the founder, chief scientific officer, and executive vice president of research and development at Deverra Therapeutics. Founded in 2019, Deverra has an exclusive license from Fred Hutchinson Cancer Research Center for a stem cell expansion and directed-differentiation platform.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Univ. of Washington rolls out new licensing process to streamline negotiations with spinouts

GeekWire

The University of Washington is aiming to make it easier for spinouts to get out of the research lab and into the market. This week the UW unveiled Husky FAST Start , a new licensing process meant to speed up startup license discussions. universities more control over technology licensing. public university.

Licensing 125
article thumbnail

The early returns on gen AI for software development

CIO Business Intelligence

Generative AI is already having an impact on multiple areas of IT, most notably in software development. Still, gen AI for software development is in the nascent stages, so technology leaders and software teams can expect to encounter bumps in the road.

article thumbnail

Microsoft calls for ‘safety brakes,’ licensing, and a new federal agency to avoid AI pitfalls

GeekWire

Develop a broad legal and regulatory framework based on the technology architecture for AI, including new regulations and licensing for powerful AI foundation models and obligations for AI infrastructure operators. There needs to be measurement, and ultimately, like so much else in life … AI will require a license.”

Licensing 100
article thumbnail

IBM will no longer offer, develop, or research facial recognition technology

The Verge

The company will also no longer develop or research the technology, IBM tells The Verge. But IBM was also found to be sharing a separate training data set of nearly one million photos in January 2019 taken from Flickr without the consent of the subjects — though the photos were shared under a Creative Commons license.

IBM 145
article thumbnail

Released from court oversight, a Seattle research institution rebrands and resets

GeekWire

When a court-appointed overseer took hold of the operations of the Infectious Disease Research Institute in early 2020 it was unclear how the Seattle organization would weather the change. The institute now focuses on a few core technologies that it can license at earlier stages to biopharma companies.